deltatrials
Recruiting PHASE3 INTERVENTIONAL 1-arm NCT06134167

A Study to Evaluate the Safety and Effectiveness Transdermal Compress Device in Participants With Transfemoral Amputations

A Prospective, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Effectiveness of the Transdermal Compress Device in Participants With Transfemoral Amputations

Sponsor: Balmoral Medical company

Updated 13 times since 2023 Last updated: Mar 6, 2026 Started: Jun 11, 2024 Primary completion: Dec 31, 2030 Completion: Jun 30, 2031
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Prosthesis and Implants, this trial is actively recruiting participants. The trial is conducted by Balmoral Medical company and has accumulated 13 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2023 – ~May 2024 · 5 months · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Apr 2025 · 4 months · monthly snapshot~Apr 2025 – ~Aug 2025 · 4 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – ~Nov 2025 · 2 months · monthly snapshot~Nov 2025 – ~Jan 2026 · 2 months · monthly snapshot~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshot~Feb 2026 – ~Mar 2026 · 28 days · monthly snapshot~Mar 2026 – present · 5 months · monthly snapshot

Change History

13 versions recorded
  1. Mar 2026 — Present [monthly]

    Recruiting PHASE3

  2. Feb 2026 — Mar 2026 [monthly]

    Recruiting PHASE3

  3. Jan 2026 — Feb 2026 [monthly]

    Recruiting PHASE3

  4. Nov 2025 — Jan 2026 [monthly]

    Recruiting PHASE3

  5. Sep 2025 — Nov 2025 [monthly]

    Recruiting PHASE3

Show 8 earlier versions
  1. Aug 2025 — Sep 2025 [monthly]

    Recruiting PHASE3

  2. Apr 2025 — Aug 2025 [monthly]

    Recruiting PHASE3

  3. Dec 2024 — Apr 2025 [monthly]

    Recruiting PHASE3

  4. Sep 2024 — Dec 2024 [monthly]

    Recruiting PHASE3

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  6. Jun 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  7. May 2024 — Jun 2024 [monthly]

    Not Yet Recruiting PHASE3

  8. Dec 2023 — May 2024 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Balmoral Medical company
Data source: Balmoral Medical company

For direct contact, visit the study record on ClinicalTrials.gov .